haloperidol has been researched along with sincalide in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 32 (80.00) | 18.7374 |
| 1990's | 2 (5.00) | 18.2507 |
| 2000's | 2 (5.00) | 29.6817 |
| 2010's | 4 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altenbach, RJ; Brioni, JD; Carr, TL; Chandran, P; Cowart, MD; Esbenshade, TA; Honore, P; Hsieh, GC; Lewis, LG; Liu, H; Manelli, AM; Marsh, KC; Milicic, I; Miller, TR; Strakhova, MI; Vortherms, TA; Wakefield, BD; Wetter, JM; Witte, DG | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bednarski, M; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pękala, E; Powroźnik, B; Słoczyńska, K; Walczak, M; Waszkielewicz, AM; Żesławska, E | 1 |
| Filipek, B; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pańczyk, K; Pękala, E; Rapacz, A; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D; Żesławska, E | 1 |
| Wood, PL | 1 |
| Lang, IM; Marvig, J | 1 |
| Ettenberg, A; Koob, GF; Weiss, F | 1 |
| Hu, XT; Wang, RY | 1 |
| Blaha, CD; Lane, RF; Phillips, AG | 1 |
| Fukamauchi, F; Kaneno, S; Shibuya, H; Takahashi, R; Yoshikawa, T | 1 |
| Zetler, G | 7 |
| Kádár, T; Kovács, K; Penke, B; Telegdy, G | 1 |
| Agnati, LF; Battistini, N; Benfenati, F; Calza, L; Fuxe, K; Giardino, L; Guidolin, D; Ruggeri, M; Vanderhaeghen, JJ; Zoli, M | 1 |
| Kato, T; Takita, M | 1 |
| Allikmets, L; Maimets, M; Nurk, A; Soosaar, A; Vasar, E | 1 |
| Matsubara, K; Matsushita, A | 1 |
| Ettenberg, A; Weiss, F | 1 |
| Jiang, LH; Kasser, RJ; Wang, RY | 1 |
| Altar, CA; Boyar, WC; Oei, E; Wood, PL | 1 |
| Király, I; Van Ree, JM | 1 |
| Casamenti, F; Florian, A; Magnani, M; Pepeu, G | 1 |
| Biziere, K; Briet, C; Castro, B; Martinez, J; Worms, P | 1 |
| Cohen, SL | 1 |
| Borda, L; Kádár, T; Kovács, K; Penke, B; Telegdy, G | 1 |
| Chase, TN; Cohen, SL; Knight, M; Tamminga, CA | 1 |
| Frey, P | 1 |
| Billington, CJ; Gerritsen, GC; Levine, AS; Morley, JE | 1 |
| Kovács, GL; Penke, B; Szabó, G; Telegdy, G | 1 |
| Grace, M; Kneip, J; Levine, AS; Morley, JE; Murray, SS | 1 |
| Fekete, M; Hegedüs, B; Lengyel, A; Penke, B; Telegdy, G; Tóth, G; Zarándy, M | 1 |
| Felicio, LF; Nasello, AG; Palermo-Neto, J; Silva, AM; Tieppo, CA | 1 |
| Biró, E; Penke, B; Telegdy, G | 1 |
| Freeman, AS; Hamilton, ME; Redondo, JL | 1 |
| Aracil-Fernández, A; Berbel, P; Manzanares, J; Navarrete, F; Navarro, D; Ortega-Álvaro, A | 1 |
1 review(s) available for haloperidol and sincalide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
39 other study(ies) available for haloperidol and sincalide
| Article | Year |
|---|---|
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Carrageenan; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Humans; Hyperalgesia; Ligands; Mice; Molecular Structure; Pain; Peritonitis; Quinazolines; Rats; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Stereoisomerism; Structure-Activity Relationship | 2008 |
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.
Topics: Amino Alcohols; Animals; Anticonvulsants; Chemistry, Physical; Dose-Response Relationship, Drug; Drug Design; Epilepsy; Male; Mice; Microsomes, Liver; Molecular Structure; Pilocarpine | 2016 |
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship | 2017 |
CCK modulation of cerebellar afferents: dopaminergic involvement.
Topics: Amphetamine; Animals; Apomorphine; Cerebellum; Cyclic GMP; Dopamine; Haloperidol; Male; Mice; Reference Values; Sincalide | 1989 |
Functional localization of specific receptors mediating gastrointestinal motor correlates of vomiting.
Topics: Animals; Apomorphine; Atropine; Copper; Copper Sulfate; Digestive System; Dogs; Domperidone; Female; Gastrointestinal Motility; Haloperidol; Hexamethonium; Hexamethonium Compounds; Male; Muscle Contraction; Naloxone; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Neurotransmitter; Receptors, Opioid; Receptors, Serotonin; Serotonin Antagonists; Sincalide; Vomiting | 1989 |
CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats.
Topics: Animals; Antipsychotic Agents; Apomorphine; Brain Chemistry; Flupenthixol; Haloperidol; Hydroxydopamines; Injections; Male; Motor Activity; Nucleus Accumbens; Oxidopamine; Rats; Rats, Inbred Strains; Septal Nuclei; Sincalide; Sympathectomy, Chemical | 1989 |
Haloperidol and clozapine: differential effects on the sensitivity of caudate-putamen neurons to dopamine agonists and cholecystokinin following one month continuous treatment.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Benzazepines; Cholecystokinin; Clozapine; Corpus Striatum; Dibenzazepines; Ergolines; Haloperidol; Male; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sincalide | 1989 |
Cholecystokinin-induced inhibition of dopamine neurotransmission: comparison with chronic haloperidol treatment.
Topics: Animals; Apomorphine; Dopamine; Haloperidol; Male; Neural Inhibition; Nucleus Accumbens; Rats; Receptors, Dopamine; Septal Nuclei; Sincalide; Synaptic Transmission | 1987 |
Dopaminergic agents affected neuronal transmission of cholecystokinin in the rat brain.
Topics: Animals; Brain; Haloperidol; Immune Sera; Male; Methamphetamine; Radioimmunoassay; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sincalide; Synaptic Transmission | 1987 |
Antistereotypic effects of cholecystokinin octapeptide (CCK-8), ceruletide and related peptides on apomorphine-induced gnawing in sensitized mice.
Topics: Animals; Antipsychotic Agents; Apomorphine; Ceruletide; Dose-Response Relationship, Drug; Haloperidol; Humans; Irritants; Male; Mice; Scopolamine; Sincalide; Stereotyped Behavior; Thioxanthenes; Trifluoperazine | 1985 |
Inhibition of haloperidol-induced catalepsy by cholecystokinin octapeptides after central administration to rats.
Topics: Animals; Antipsychotic Agents; Catalepsy; Haloperidol; Humans; Injections, Intraventricular; Male; Rats; Sincalide; Time Factors | 1985 |
Evidence for cholecystokinin-dopamine receptor interactions in the central nervous system of the adult and old rat. Studies on their functional meaning.
Topics: Aging; Animals; Apomorphine; Brain; Cholecystokinin; Haloperidol; Male; Neurons; Nucleus Accumbens; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sincalide; Tyrosine 3-Monooxygenase | 1985 |
Antistereotype effects of ceruletide and some neuroleptics differentiated by interactions with clonazepam, muscimol, scopolamine and clonidine.
Topics: Animals; Antipsychotic Agents; Ceruletide; Clonazepam; Clonidine; Clopenthixol; Fluphenazine; Haloperidol; Male; Methylphenidate; Mice; Muscimol; Scopolamine; Sincalide; Stereotyped Behavior | 1986 |
Cholecystokinin system in striatal-nigral neuronal networks: infusion of quinolinic acid into rat striatum.
Topics: Animals; Cholecystokinin; Corpus Striatum; Enzyme-Linked Immunosorbent Assay; gamma-Aminobutyric Acid; Haloperidol; Male; Pyridines; Quinolinic Acids; Rats; Rats, Inbred Strains; Sincalide; Substantia Nigra | 1989 |
Comparison of motor depressant effects of caerulein and N-propylnorapomorphine in mice.
Topics: 5,7-Dihydroxytryptamine; Animals; Apomorphine; Ceruletide; Depression, Chemical; Exploratory Behavior; Fenclonine; Haloperidol; Hydroxydopamines; Male; Mice; Motor Activity; Nerve Endings; Oxidopamine; Receptors, Dopamine; Receptors, Serotonin; Sincalide; Spiperone | 1986 |
beta-Endorphin involvement in the antidopaminergic effect of caerulein.
Topics: Amphetamine; Animals; beta-Endorphin; Ceruletide; Endorphins; Haloperidol; Hypophysectomy; Injections, Intraventricular; Male; Motor Activity; Naloxone; Nucleus Accumbens; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sincalide | 1986 |
Comparison of circling induced by unilateral intrastriatal microinjections of haloperidol, clozapine and CCK-8 in rats.
Topics: Animals; Clozapine; Corpus Striatum; Dextroamphetamine; Dibenzazepines; Dopamine; Haloperidol; Male; Microinjections; Motor Activity; Rats; Rats, Inbred Strains; Sincalide; Synaptic Transmission | 1986 |
Cholecystokinin antagonist lorglumide reverses chronic haloperidol-induced effects on dopamine neurons.
Topics: Action Potentials; Animals; Dopamine; Glutamine; Haloperidol; Male; Nucleus Accumbens; Proglumide; Rats; Rats, Inbred Strains; Septal Nuclei; Sincalide; Substantia Nigra | 1988 |
Cholecystokinin attenuates basal and drug-induced increases of limbic and striatal dopamine release.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cerebral Cortex; Corpus Striatum; Dextroamphetamine; Dopamine; Haloperidol; Homovanillic Acid; Male; Mice; Mice, Inbred Strains; Olfactory Bulb; Reference Values; Sincalide; Tyramine | 1988 |
Behavioral evidence for the involvement of endogenous opioids in the interaction between cholecystokinin and brain dopamine systems.
Topics: Animals; Apomorphine; Dopamine; Endorphins; Haloperidol; Male; Motor Activity; Naloxone; Nucleus Accumbens; Rats; Rats, Inbred Strains; Septal Nuclei; Sincalide | 1987 |
An analysis of cholecystokinin-induced increase in acetylcholine output from cerebral cortex of the rat.
Topics: Acetylcholine; Animals; Cerebral Cortex; Cholecystokinin; Haloperidol; Male; Rats; Rats, Inbred Strains; Sincalide | 1987 |
Evidence for dopaminomimetic effect of intrastriatally injected cholecystokinin octapeptide in mice.
Topics: Animals; Apomorphine; Corpus Striatum; Drug Interactions; Female; Haloperidol; Injections; Mice; Proglumide; Receptors, Dopamine; Sincalide; Stereotyped Behavior | 1986 |
A pharmacological examination of the resistance-to-change hypothesis of response strength.
Topics: Animals; Conditioning, Operant; Dextroamphetamine; Haloperidol; Male; Pentobarbital; Rats; Rats, Inbred Strains; Reinforcement Schedule; Sincalide | 1986 |
Cataleptogenic and anticataleptic activity produced by cholecystokinin octapeptides in mice.
Topics: Animals; Catalepsy; Drug Interactions; Haloperidol; Humans; Injections, Intraventricular; Injections, Subcutaneous; Male; Mice; Sincalide | 1985 |
Clonidine and yohimbine separate the sedation and the ptosis caused by cholecystokinin octapeptide and ceruletide.
Topics: Animals; Apomorphine; Blepharoptosis; Catalepsy; Ceruletide; Clonidine; Drug Antagonism; Haloperidol; Humans; Hypnotics and Sedatives; Male; Mice; Motor Activity; Sincalide; Yohimbine | 1984 |
Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Catalepsy; Cholecystokinin; Extinction, Psychological; Female; Haloperidol; Humans; Hypnotics and Sedatives; Peptide Fragments; Rats; Rats, Inbred Strains; Sincalide; Stereotyped Behavior; Tetragastrin | 1982 |
Neuroleptic-like effects of ceruletide and cholecystokinin octapeptide: interactions with apomorphine, methylphenidate and picrotoxin.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Blepharoptosis; Body Temperature; Ceruletide; Clonazepam; Drug Antagonism; Haloperidol; Male; Methylphenidate; Mice; Peptide Fragments; Picrotoxin; Sincalide | 1983 |
Cholecystokinin octapeptide levels in rat brain are changed after subchronic neuroleptic treatment.
Topics: Animals; Antipsychotic Agents; Brain Chemistry; Chlorpromazine; Cholecystokinin; Clozapine; Haloperidol; Male; Rats; Rats, Inbred Strains; Sincalide; Tetragastrin | 1983 |
Feeding systems in Chinese hamsters.
Topics: Animals; Brain; Calcitonin; Circadian Rhythm; Cricetinae; Cyclazocine; Diabetes Mellitus; Dynorphins; Eating; Endorphins; Ethylketocyclazocine; Feeding Behavior; Haloperidol; Mesocricetus; Naloxone; Peptide Fragments; Phenazocine; Sincalide; Starvation | 1984 |
Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice.
Topics: alpha-Methyltyrosine; Animals; Apomorphine; Cholecystokinin; Corpus Striatum; Dopamine; Drug Interactions; Haloperidol; Humans; Male; Methyltyrosines; Mice; Naloxone; Receptors, Dopamine; Sincalide; Stereotyped Behavior | 1981 |
Anticonvulsant effects of caerulein, cholecystokinin octapeptide (CCK-8) and diazepam against seizures produced in mice by harman, thiosemicarbazide and isoniazid.
Topics: Animals; Anticonvulsants; Ceruletide; Cholecystokinin; Diazepam; Haloperidol; Harmine; Isoniazid; Male; Mice; Mice, Inbred Strains; Seizures; Semicarbazides; Sincalide | 1981 |
Central depressant effects of caerulein and cholecystokinin octapeptide (CCK-8) differ from those of diazepam and haloperidol.
Topics: Animals; Anticonvulsants; Catalepsy; Central Nervous System Depressants; Ceruletide; Cholecystokinin; Diazepam; Dose-Response Relationship, Drug; Haloperidol; Humans; Male; Mice; Receptors, Dopamine; Sincalide; Sleep; Stereotyped Behavior | 1981 |
Peptidergic regulation of stress-induced eating.
Topics: Animals; Appetite Depressants; Atropine; Bombesin; Carbachol; Cholecystokinin; Enkephalin, Methionine; Enkephalins; Feeding Behavior; Haloperidol; Humans; Isoproterenol; Male; Muscimol; Naloxone; Norepinephrine; Peptide Fragments; Peptides; Phentolamine; Quipazine; Rats; Rats, Inbred Strains; Sincalide; Stress, Psychological | 1982 |
Cholecystokinin octapeptide, caerulein and caerulein analogues: effects on thermoregulation in the mouse.
Topics: Animals; Body Temperature Regulation; Ceruletide; Cholecystokinin; Dose-Response Relationship, Drug; Haloperidol; Male; Mice; Morphine; Peptide Fragments; Sincalide; Time Factors | 1982 |
Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats.
Topics: Amygdala; Animals; Avoidance Learning; Chlordiazepoxide; Haloperidol; Injections, Intravenous; Injections, Intraventricular; Male; Motor Activity; Nucleus Accumbens; Rats; Rats, Inbred Strains; Sincalide; Structure-Activity Relationship; Time Factors | 1984 |
Intracerebroventricular administration of cholecystokinin reduces stereotypy in dopamine-supersensitive rats.
Topics: Analysis of Variance; Animals; Apomorphine; Cholecystokinin; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Injections, Intraventricular; Male; Rats; Rats, Wistar; Sincalide; Stereotyped Behavior | 1995 |
Role of different neurotransmitter systems in the cholecystokinin octapeptide-induced anxiogenic response in rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Anxiety; Atropine; Bicuculline; Dopamine Antagonists; GABA Antagonists; Haloperidol; Injections, Intraventricular; Male; Methysergide; Muscarinic Antagonists; Naloxone; Narcotic Antagonists; Phenoxybenzamine; Propranolol; Rats; Rats, Wistar; Serotonin Antagonists; Sincalide | 1997 |
Overflow of dopamine and cholecystokinin in rat nucleus accumbens in response to acute drug administration.
Topics: Animals; Dextroamphetamine; Dopamine; Dopamine Agents; Dopamine Antagonists; Haloperidol; Male; Morphine; Narcotics; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Sincalide | 2000 |
Differential Pharmacological Regulation of Sensorimotor Gating Deficit in CB1 Knockout Mice and Associated Neurochemical and Histological Alterations.
Topics: Animals; Cannabinoid Receptor Antagonists; Central Nervous System Agents; Cerebral Cortex; Cholecystokinin; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Gene Expression; Haloperidol; Immunohistochemistry; Male; Methylphenidate; Mice, Knockout; Neurons; Parvalbumins; Peptide Fragments; Piperidines; Prepulse Inhibition; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Adrenergic, alpha-2; Risperidone; Time Factors | 2015 |